A Study in People With Advanced Cancer to Test How BI 907828 is Processed in the Body

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 3, 2023

Primary Completion Date

April 25, 2024

Study Completion Date

January 13, 2025

Conditions

Solid Tumors

Interventions

DRUG

[¹⁴C]-BI 907828 mixed with BI 907828 (formulation 1)

\[¹⁴C\]-BI 907828 mixed with BI 907828 (formulation 1)

DRUG

[¹⁴C]-BI 907828 mixed with BI 907828 (formulation 2)

\[¹⁴C\]-BI 907828 mixed with BI 907828 (formulation 2)

DRUG

BI 907828

Trial Locations (1)

PRA Hungary Ltd., Budapest